Physician

Sadia Syed, M.D.

According to 2025 Medicare claims, Sadia Syed, M.D. (NPI: 1518367333) practices infectious disease in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is METRO INFECTIOUS DISEASE CONSULTANTS, LLC (NPI: 1235125717; TIN: 363966745) and primary practice location at 60048-3100. Syed is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Syed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 18,009 HCPCS/CPT codes, and received $486,204 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 313 prescription claims across 157 beneficiaries totaling $90,123 in drug costs, led by Tivicay (Dolutegravir Sodium). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,264 to $486,204. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,318 and ending at $90,123. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$243K$486K2018 Medicare payment: $1,264 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,333 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,661 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $472,971 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $392,383 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $452,005 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $486,204 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181726$1,264
20191319$1,333
20203965$4,661
202162328,386$472,971
202263849,371$392,383
202366321,912$452,005
202452618,009$486,204

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$164K$327K2015 Drug cost: $7,318 (USD; Tot_Drug_Cst)2016 Drug cost: $2,204 (USD; Tot_Drug_Cst)2017 Drug cost: $40,986 (USD; Tot_Drug_Cst)2018 Drug cost: $214,167 (USD; Tot_Drug_Cst)2019 Drug cost: $327,408 (USD; Tot_Drug_Cst)2020 Drug cost: $203,663 (USD; Tot_Drug_Cst)2021 Drug cost: $21,690 (USD; Tot_Drug_Cst)2022 Drug cost: $30,527 (USD; Tot_Drug_Cst)2023 Drug cost: $20,882 (USD; Tot_Drug_Cst)2024 Drug cost: $90,123 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152398$7,318
20161442$2,204
20172292$40,986
201828189$214,167
201914163$327,408
202012112$203,663
202186194$21,690
2022103191$30,527
20234889$20,882
2024157313$90,123

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes279327$138
96413Administration of chemotherapy into vein, 1 hour or less2124$106
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4001,680$95
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle3639$59
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more3136$45

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TivicayDolutegravir Sodium11330$28,313
DaptomycinDaptomycin23176$18,084
LamivudineLamivudine11330$2,943
Vancomycin HclVancomycin Hcl17274$2,861
CeftriaxoneCeftriaxone Sodium21168$1,678

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Sadia Syed, M.D.?

Tedicare shows public-source Medicare data for Sadia Syed, M.D. (NPI 1518367333), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sadia Syed, M.D. have ACO affiliation data?

Sadia Syed, M.D. is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Sadia Syed, M.D.?

Sadia Syed, M.D. is linked to METRO INFECTIOUS DISEASE CONSULTANTS, LLC (billing NPI 1235125717) in the available physician profile data.

Does Sadia Syed, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.